Clinical Trial Update: A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer [NA]

View source ↗

Summary

This is an update on a completed dose-escalation trial of liposomal doxorubicin (doxorubicin hydrochloride liposome) for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin Hydrochloride Liposome Injection (liposomal doxorubicin)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | NA | Status: COMPLETED